Type I Interferon acts as a major barrier to the establishment of infectious bursal disease virus (IBDV) persistent infections.
Broto L, Romero N, Méndez F, Diaz-Beneitez E, Candelas-Rivera O, Fuentes D, Cubas-Gaona LL, Courtillon C, Eterradossi N, Soubies SM, Rodríguez JR, Rodríguez D, Rodríguez JF.
Broto L, et al. Among authors: rodriguez jf, rodriguez d, rodriguez jr.
J Virol. 2021 Mar 1;95(5):e02017-20. doi: 10.1128/JVI.02017-20. Epub 2020 Dec 16.
J Virol. 2021.
PMID: 33328313
Free PMC article.